(Reuters) -Danco Laboratories plans to ask the U.S. Food and Drug Administration to approve its abortion pill regimen for management of miscarriages, the Wall Street Journal reported on Tuesday.
Some doctors and women already use the pill, called Mifeprex, or its generic equivalent mifepristone, without the FDA’s official signoff to treat miscarriages, the report said, citing people familiar with the matter.
Mifeprex was approved by the FDA in 2000 to perform medication abortion, which accounts for more than half of all U.S. abortions.
Danco did not immediately respond to Reuters request for comment.
(Reporting by Mariam Sunny and Bhanvi Satija in Bengaluru; Editing by Leroy Leo)
